C57BL/6N-Reltm1a(EUCOMM)Wtsi/H
Status | Available to order |
EMMA ID | EM:07990 |
International strain name | C57BL/6N-Reltm1a(EUCOMM)Wtsi/H |
Alternative name | EPD0463_4_D10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Reltm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Rel |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0463_4_D10. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- extramedullary hematopoiesis / MGI
- decreased bone marrow cell number / MGI
- abnormal stomach morphology / MGI
- abnormal liver morphology / MGI
- abnormal spleen morphology / MGI
- enlarged spleen / MGI
- enlarged lymph nodes / MGI
- abnormal lung morphology / MGI
- dermatitis / MGI
- impaired hematopoiesis / MGI
- abnormal humoral immune response / MGI
- decreased IgG level / MGI
- decreased IgM level / MGI
- premature death / MGI
- no abnormal phenotype detected / MGI
- abnormal dendritic cell physiology / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal leukocyte physiology / MGI
- abnormal T cell physiology / MGI
- abnormal macrophage morphology / MGI
- abnormal macrophage physiology / MGI
- abnormal professional antigen presenting cell physiology / MGI
- decreased IgE level / MGI
- increased IgM level / MGI
- increased IgA level / MGI
- abnormal cytokine secretion / MGI
- abnormal cell cycle / MGI
- increased neuron apoptosis / MGI
- impaired macrophage chemotaxis / MGI
- decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- decreased B-1 B cell number / MGI
- increased eosinophil cell number / MGI
- increased T cell number / MGI
- decreased susceptibility to parasitic infection / MGI
- decreased cytotoxic T cell cytolysis / MGI
- decreased B cell proliferation / MGI
- decreased T cell proliferation / MGI
- immune system phenotype / MGI
- respiratory system phenotype / MGI
- abnormal CD4-positive, alpha-beta T cell physiology / MGI
- abnormal skeleton morphology / MGI
- decreased apoptosis / MGI
- abnormal DNA replication / MGI
- increased CD4-positive, alpha beta T cell number / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- increased CD8-positive, alpha-beta T cell number / MGI
- decreased CD8-positive, alpha-beta T cell number / MGI
- abnormal T-helper 1 cell differentiation / MGI
- abnormal memory B cell number / MGI
- abnormal spleen B cell follicle morphology / MGI
- decreased spleen germinal center number / MGI
- decreased IgG1 level / MGI
- decreased IgG2a level / MGI
- decreased IgG2b level / MGI
- decreased IgG3 level / MGI
- increased IgG2a level / MGI
- abnormal splenic cell ratio / MGI
- increased effector memory CD4-positive, alpha-beta T cell number / MGI
- decreased response to antigen / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).